<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
<title>Ftiziopneumologie</title>
<link href="http://repository.usmf.md:80/xmlui/handle/20.500.12710/467" rel="alternate"/>
<subtitle/>
<id>http://repository.usmf.md:80/xmlui/handle/20.500.12710/467</id>
<updated>2026-04-28T19:28:11Z</updated>
<dc:date>2026-04-28T19:28:11Z</dc:date>
<entry>
<title>Durata incapacităţii temporare de muncă bolnavilorcu astm bronşic</title>
<link href="http://repository.usmf.md:80/xmlui/handle/20.500.12710/3735" rel="alternate"/>
<author>
<name>Moscovciuc, Ana</name>
</author>
<author>
<name>Simionică, Iurie</name>
</author>
<author>
<name>Scaleţchi, Valentina</name>
</author>
<author>
<name>Munteanu, Neonela</name>
</author>
<author>
<name>Martîniuc, Constantin</name>
</author>
<id>http://repository.usmf.md:80/xmlui/handle/20.500.12710/3735</id>
<updated>2019-06-25T09:06:33Z</updated>
<published>2009-01-01T00:00:00Z</published>
<summary type="text">Durata incapacităţii temporare de muncă bolnavilorcu astm bronşic
Moscovciuc, Ana; Simionică, Iurie; Scaleţchi, Valentina; Munteanu, Neonela; Martîniuc, Constantin
The bronchial asthma represents a global problem of health protection system. The incident of bronchial asthma in different countries varies from 1% to 18%. Considerable economic loss is caused by direct and indirect medical expenses, that included a number of days that patients were absents from work.&#13;
The study of the terms of temporary work incapacity in different variants of clinical evolution of bronchial asthma in 51 patients, revealed evident dependence of temporary work incapacity's duration of the grade of severity of bronchial asthma: in mild evolution - 9,9 days; moderate evolution - 12,5 days and severe evolution - 17,1 days.&#13;
The criteria of the recovery of the patient's work capacity recuperation for further work were determined not only by clinical and functional factors, but and by different social factors.&#13;
&#13;
&#13;
&#13;
&#13;
&#13;
&#13;
Astmul bronşic reprezintă o problemă globală a sistemului Ocrotirii Sănătăţii. Incidenţa astmului bronşic în diferite ţări variază de la 1% pînă la 18%. Pierderile economice considerabile sunt cauzate de factori direct medicali, precum şi indirecti, care includ numărul de zile absentate în cîmpul de muncă.&#13;
Studierea termenilor incapacităţii temporare de muncă în diferite variante a evoluţiei clinice a astmului bronşic la 51 pacienţi a relevat o dependenţă evidentă a duratei independenţă de gradul severităţii astmului bronşic: evoluţie uşoară - 9,9 zile; evoluţie medie - 12,5 zile; evoluţie gravă - 17,1 zile.&#13;
Criteriile de restabilire a capacităţii de muncă la pacienţi au fost determinate nu numai de factori clinici şi funcţionali, dar şi de cei sociali.
IMSP Institutul de Ftiziopneumologie „Chiril Draganiuc”
</summary>
<dc:date>2009-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Pneumonia comunitară cu evoluţie severă: etiologie, diagnostic şi prognostic</title>
<link href="http://repository.usmf.md:80/xmlui/handle/20.500.12710/3732" rel="alternate"/>
<author>
<name>Zlepca, Vasile</name>
</author>
<author>
<name>Caraiani, Olga</name>
</author>
<id>http://repository.usmf.md:80/xmlui/handle/20.500.12710/3732</id>
<updated>2019-06-25T09:06:33Z</updated>
<published>2009-01-01T00:00:00Z</published>
<summary type="text">Pneumonia comunitară cu evoluţie severă: etiologie, diagnostic şi prognostic
Zlepca, Vasile; Caraiani, Olga
Pneumonia with severe evolution  puts in danger patient`s life in most cases, especially old people. 14 cases of pneumonia with severe evolution were estimated and monitorized. They comprised 9 patients  aged over 60 years.&#13;
The etiology of severe pneumonias was: Klebsiella pneumoniae 21,4%, Streptococcus pneumoniae 21,4%, Stafilococcus aureus, in 7,2% and 50% cases the cause wasn’t found. The volume of pulmonary infiltration in 42,9% cases was polisegmentary and in 21,5% cases   bilateral. Complications: respiratory failure  95,2%. Treatment  constituted in averrage 5,3 days, being accompanied by significant financial effort.&#13;
&#13;
&#13;
&#13;
&#13;
&#13;
Pneumonie severă pune în pericol viaţa pacientului în majoritatea cazurilor, în deosebi la bătrâni. Au fost evoluate şi monitorizate 14 cazuri de pneumonie severă, inclusiv 9 bolnavi cu vârsta peste 60 de ani.&#13;
Etiologia pneumoniilor severe au fost: Klebsiella pneumoniae 21,4%, Streptococcus pneumoniae 21,4%, Stafilococcus aureus 7,2% şi 50% cazuri etiologia nu a fost depistată. Volumul infiltratului pulmonar în 42,9% cazuri era polisegmentar şi 21,5% cazuri bilateral.&#13;
Complicaţii: insuficienţa respiratorie a fost acompaniată de 95%. Durata tratamentului a constituit în mediu 5,3 zile pat, acompaniată de eforturi financiare însemnate.
FPM USMF „Nicolae Testemiţanu”
</summary>
<dc:date>2009-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Optimizarea tratamentului bolnavilor cu sindromul bronhoobstructiv</title>
<link href="http://repository.usmf.md:80/xmlui/handle/20.500.12710/3730" rel="alternate"/>
<author>
<name>Butorov, Ivan V.</name>
</author>
<author>
<name>Butorov, Valentina</name>
</author>
<author>
<name>Antonova, Natalia</name>
</author>
<author>
<name>Calancea, Valentin</name>
</author>
<id>http://repository.usmf.md:80/xmlui/handle/20.500.12710/3730</id>
<updated>2019-06-25T09:06:33Z</updated>
<published>2009-01-01T00:00:00Z</published>
<summary type="text">Optimizarea tratamentului bolnavilor cu sindromul bronhoobstructiv
Butorov, Ivan V.; Butorov, Valentina; Antonova, Natalia; Calancea, Valentin
Accessory fenspirid inclusion in the complex therapy of patients with chronic pulmonary obstructive disease reduces the main clinical signs of the disease, normalizes the biochemical blood parameters, and improves the parameters of forced expiration. The usage of fenspirid in the treatment of patients with bronchial asthma and chronic pulmonary obstructive disease has particular advantages in comparison with standard scheme, which permits to recommend it’s inclusion in current therapeutically schemas of pulmonary respiratory diseases aggravation.&#13;
&#13;
&#13;
&#13;
Includerea remediului fenspirid în programul complex de tratament al pacienţilor cu astm bronşic (AB) şi bronhopneumopatie cronică obstructivă (BPCO) micşorează intensitatea simptoamelor clinice principale ale maladiei, normalizează parametrii biologici ai sângelui, ameliorează indicii funcţiei respiraţiei externe (FRE). Asocierea preparatului fenspirid avantajează schema de tratament standard al pacienţilor cu AB şi BPCO, ce permite de a recomanda acestui preparat în tactica curativă contemporană al exacerbărilor afecţiunilor cronice pulmonare.
Catedra medicina internă N6 USMF “Nicolae Testemiţanu”
</summary>
<dc:date>2009-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Particularităţile tuberculozei la persoane social dezadaptate  în municipiul Chişinău</title>
<link href="http://repository.usmf.md:80/xmlui/handle/20.500.12710/3734" rel="alternate"/>
<author>
<name>Maxian, Iuliana</name>
</author>
<author>
<name>Chiforiuc, Eugen</name>
</author>
<id>http://repository.usmf.md:80/xmlui/handle/20.500.12710/3734</id>
<updated>2019-06-25T09:06:33Z</updated>
<published>2009-01-01T00:00:00Z</published>
<summary type="text">Particularităţile tuberculozei la persoane social dezadaptate  în municipiul Chişinău
Maxian, Iuliana; Chiforiuc, Eugen
The data of 95 patients without a residence with pulmonary tuberculosis who have been inregistreted last free years in mun.Chisinau  have been studied. At 35 (36,8%) diagnosis has been exposed postmortem. From 54 of patients with dilated TB process has been inregistrated 63.0% with elimination of bacilli. Pozitive rezults of treatment in 24.2% has been fixed only, with abandon-38.9% and 25,9% died. People without a residence promote deterioration of epidemiological situation and demand special attention.&#13;
&#13;
&#13;
&#13;
&#13;
&#13;
Au fost ananlizate datele a 95 persoane fără loc de trai cu tuberculoza pulmonară înregistrate în ultimii trei ani în mun. Chişinău. La 35 (36,8%) diagnosticul a fost stabilit postmortem. Din 54 bolnavi cu diferite forme avansate de TB erau baciliferi 63,0%. Rezultatele pozitive a tratamentului s-au constatat numai la 24,2%, au abandonat tratamentul 38,9%, iar 25,9% din pacienţi au decedat. Persoanele fără loc de trai contribuie la agravarea situaţiei epidemiologice în municipiu şi necesită o atenţie deosebită.
Catedra Pneumoftiziologie USMF „Nicolae Testemiţanu”
</summary>
<dc:date>2009-01-01T00:00:00Z</dc:date>
</entry>
</feed>
